DE2808523C2 - - Google Patents

Info

Publication number
DE2808523C2
DE2808523C2 DE2808523A DE2808523A DE2808523C2 DE 2808523 C2 DE2808523 C2 DE 2808523C2 DE 2808523 A DE2808523 A DE 2808523A DE 2808523 A DE2808523 A DE 2808523A DE 2808523 C2 DE2808523 C2 DE 2808523C2
Authority
DE
Germany
Prior art keywords
radical
pyridyl
disulfide
reaction
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2808523A
Other languages
German (de)
English (en)
Other versions
DE2808523A1 (de
Inventor
Jan Per Erik Uppsala Se Carlsson
Rolf Erik Axel Verner Baelinge Se Axen
Haakan Nils Yngve Brunna Se Drevin
Goeran Einar Samuel Almunge Se Lindgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Pharmacia Fine Chemicals AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals AB filed Critical Pharmacia Fine Chemicals AB
Publication of DE2808523A1 publication Critical patent/DE2808523A1/de
Application granted granted Critical
Publication of DE2808523C2 publication Critical patent/DE2808523C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19782808523 1977-03-04 1978-02-28 Neue pyridinverbindungen sowie deren verwendung Granted DE2808523A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens

Publications (2)

Publication Number Publication Date
DE2808523A1 DE2808523A1 (de) 1978-09-07
DE2808523C2 true DE2808523C2 (US20070117153A1-20070524-C00031.png) 1987-11-19

Family

ID=20330623

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782808523 Granted DE2808523A1 (de) 1977-03-04 1978-02-28 Neue pyridinverbindungen sowie deren verwendung

Country Status (6)

Country Link
US (1) US4149003A (US20070117153A1-20070524-C00031.png)
JP (2) JPS53130674A (US20070117153A1-20070524-C00031.png)
DE (1) DE2808523A1 (US20070117153A1-20070524-C00031.png)
FR (1) FR2382450A1 (US20070117153A1-20070524-C00031.png)
GB (1) GB1597756A (US20070117153A1-20070524-C00031.png)
SE (1) SE430062B (US20070117153A1-20070524-C00031.png)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
SE446184B (sv) * 1979-01-12 1986-08-18 Toyo Jozo Kk Polyfunktionell disulfidforening anvendbar som tverbindande medel
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4563304A (en) * 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
SE8102193L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och dess anvendning
SE8102194L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
FR2522269A1 (fr) * 1982-02-26 1983-09-02 Pasteur Institut Agents antitumoraux, tels que la daunorubicine, a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
US4614712A (en) * 1983-02-25 1986-09-30 The Upjohn Company Immunoassays with luciferase labeled ligands or receptors
SE8302758L (sv) * 1983-05-17 1984-11-18 Pharmacia Ab Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
DE3587845T2 (de) * 1984-12-03 1994-10-20 Hoechst Celanese Corp Verfahren zur Bestimmung eines Liganden.
US4797491A (en) * 1986-03-17 1989-01-10 Cetus Corporation Compound 1-(3-(2-pyridyldithio)propionamido)-12-(5-hydrazidoglutaramido)-4,9-dioxadodecane
US4880935A (en) * 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
JPS6391563A (ja) * 1986-10-07 1988-04-22 Nitsusui Seiyaku Kk 細菌由来蛋白特異抗原の検査法
US4794082A (en) * 1987-02-17 1988-12-27 Hoechst Celanese Corporation Biotinylating agents
US4798795A (en) * 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
JPS63189278U (US20070117153A1-20070524-C00031.png) * 1987-05-28 1988-12-05
DE3809986A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Verbindungen zur einfuehrung einer sh-gruppe in tyrosin
JPH0253770U (US20070117153A1-20070524-C00031.png) * 1988-10-12 1990-04-18
JP2619549B2 (ja) * 1989-06-29 1997-06-11 日本商事株式会社 抗原の定量法およびそれに用いる固相
US5137877B1 (en) * 1990-05-14 1996-01-30 Bristol Myers Squibb Co Bifunctional linking compounds conjugates and methods for their production
WO1992001938A1 (en) * 1990-07-20 1992-02-06 City Of Hope Derivatization of c-terminal proline
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
US20030176512A1 (en) * 1998-08-11 2003-09-18 Kirkpatrick D. Lynn Asymmetric disulfides and methods of using same
US6552060B1 (en) 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
JP2006500364A (ja) * 2002-08-16 2006-01-05 イムノージェン インコーポレーテッド 高い反応性と溶解度を有する架橋剤および小分子薬物の標的化送達用コンジュゲートの調製におけるそれらの使用
AU2003284304B8 (en) 2002-10-21 2009-08-06 Nagler, Richard Surface coating comprising bioactive compound
US7858108B2 (en) 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
BRPI0511350A (pt) * 2004-07-02 2007-12-04 Genentech Inc composto, métodos de indução da apoptose em uma célula, de sensibilização de uma célula à um sinal apoptótico, de inibição da ligação de uma proteìna iap e de tratamento de uma doença e cáncer e usos de um composto
NZ555601A (en) 2004-12-09 2009-07-31 Centocor Inc Anti-integrin immunoconjugates, methods and uses
NZ589670A (en) 2004-12-20 2013-01-25 Genentech Inc Pyrrolidine inhibitors of iap
US20110166319A1 (en) * 2005-02-11 2011-07-07 Immunogen, Inc. Process for preparing purified drug conjugates
ES2503719T3 (es) * 2005-02-11 2014-10-07 Immunogen, Inc. Procedimiento para preparar conjugados de anticuerpos y de maitansinoides
EA013327B1 (ru) 2005-08-24 2010-04-30 Иммуноджен, Инк. Способ приготовления очищенных конъюгатов лекарственных средств
AU2006340014B2 (en) * 2005-12-19 2012-12-20 Genentech, Inc. Inhibitors of IAP
US20070260041A1 (en) * 2006-05-03 2007-11-08 David Crich Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfides
KR20090094461A (ko) * 2006-12-19 2009-09-07 제넨테크, 인크. Ｉａｐ의 이미다조피리딘 억제제
CA2683392A1 (en) * 2007-04-30 2008-11-06 Genentech, Inc. Inhibitors of iap
AU2009203971A1 (en) * 2008-01-11 2009-07-16 Genentech, Inc. Inhibitors of IAP
CA2730448A1 (en) 2008-08-02 2010-02-11 Genentech, Inc. Inhibitors of iap
EP3480202A1 (en) 2009-06-03 2019-05-08 ImmunoGen, Inc. Conjugation methods
RS58367B1 (sr) 2011-03-29 2019-03-29 Immunogen Inc Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
MX359599B (es) 2012-10-04 2018-09-12 Immunogen Inc Uso de una membrana de pvdf para purificar conjugados de agentes de unión celular y agentes citotóxicos.
US9518017B2 (en) 2013-06-28 2016-12-13 Immunogen, Inc. Purification of intermediates used in the preparation of heterobifunctional linkers
KR102325753B1 (ko) 2019-12-20 2021-11-11 주식회사 포스코 흑색 도금 강판 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872450A (en) * 1955-12-06 1959-02-03 Bayer Ag Thio- and dithio-carboxylic acid esters and a process for their manufacture
US3950348A (en) * 1971-12-30 1976-04-13 Merck & Co., Inc. Process for preparing e-pyridyl-4-methyloxycarbonyllysine

Also Published As

Publication number Publication date
GB1597756A (en) 1981-09-09
SE7702462L (sv) 1978-09-05
US4149003A (en) 1979-04-10
JPS624368B2 (US20070117153A1-20070524-C00031.png) 1987-01-30
JPS6121227B2 (US20070117153A1-20070524-C00031.png) 1986-05-26
JPS61191675A (ja) 1986-08-26
DE2808523A1 (de) 1978-09-07
FR2382450A1 (fr) 1978-09-29
FR2382450B1 (US20070117153A1-20070524-C00031.png) 1982-11-05
JPS53130674A (en) 1978-11-14
SE430062B (sv) 1983-10-17

Similar Documents

Publication Publication Date Title
DE2808523C2 (US20070117153A1-20070524-C00031.png)
EP0618231B1 (de) Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung
US4563304A (en) Pyridine compounds modifying proteins, polypeptides or polysaccharides
EP1386158B1 (de) Gegenstand mit einer ungeladenen, funktionalisierten hydrogeloberfläche
DE2808476C2 (de) Reagens zur Verwendung in immunochemischen Untersuchungsmethoden
EP0618192B1 (de) Homobidentale, trifunktionelle Maleinimid-Linker, und ihre Verwendung in immunologisch aktiven Konjugaten
EP0371262A1 (de) Neue Digoxigenin-Derivate und ihre Verwendung
EP0632810B1 (de) Neues biotinylierungsreagenz
WO1990015798A1 (de) Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
DE3629194A1 (de) Biotinylierungsreagentien
US4794082A (en) Biotinylating agents
EP0451810A1 (de) Hapten-Biotin-Konjugate und ihre Verwendung
EP0279365A1 (en) Biotinylating agents
EP0410280A1 (de) Heterobifunktionelle Verbindungen
DE2914842A1 (de) Reagenzien zur verwendung bei bindungsproben beim nachweis von diphenylhydantoin
EP0326074A1 (de) Neue Haptenderivate und davon abgeleitete Hapten-Protein-Konjugate
DE60017083T2 (de) Einfaches verfahren zur herstellung von markierten konjugaten
DE19529250C1 (de) Hapten-Träger-Konjugate mit hoher, definierter Kopplungsrate
EP0049860A1 (de) Verfahren zur Herstellung von reaktiven, kupplungsfähigen Derivaten der Schilddrüsenhormone T3 und T4 und deren Verwendung
EP0303062B1 (de) Stabilisiertes Peroxidasepräparat
EP0442372A1 (de) Verbesserte markierte Haptene, Verfahren zu deren Herstellung sowie Verwendung dieser markierten Haptene in Immunoassays
DE4033714C2 (US20070117153A1-20070524-C00031.png)
DE19533867C1 (de) Als Verknüpfungsreagenzien einsetzbare dimaleinimidosubstituierte Dihydroxyalkane und Verfahren zu deren Herstellung
EP0578145B1 (de) Verbindungen und Verfahren für gezieltes Photoaffinitätslabeling von Biomolekülen
EP2246342B1 (de) Triacetontriperoxid-Derivat, Verfahren zu dessen Herstellung sowie dessen Verwendung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee